Results 101 to 110 of about 11,369 (213)
Perbandingan Model Pertumbuhan Tumor Dengan Metode Pengobatan Virotherapy Dan Radiovirotherapy [PDF]
In this paper, the study was about the stability analysis and comparison of tumour growth model under the Virotherapy and Radiovirotherapy treatments. The effect of parameter values on the tumor growth for both methods presented in numerical solutions ...
Gumilang, Fajar
core +1 more source
Targeting oncogenic fusion-driven NUT carcinoma with CRISPR-Cas9 genome editing
NUT carcinoma (NC) is a highly aggressive malignancy characterized by an oncogenic fusion gene incorporating the NUTM1 gene. To date, no established treatment options exist.
Maxim F. Carle +7 more
doaj +1 more source
Turning Cold Tumors Into Hot Tumors: Implications for Cancer Therapy
Barrier‐defined strategies for cold‐to‐hot tumor conversion. Cold tumors include immune‐desert and immune‐excluded states marked by poor antigen visibility, limited T‐cell priming, stromal or vascular exclusion, metabolic stress and suppressive immune programs.
Xiao Ge +5 more
wiley +1 more source
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial [PDF]
Correction to: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 ...
Colman, Howard +38 more
core +1 more source
Applications of Oncolytic Virotherapy in Malignant Tumors
Oncolytic virotherapy, an emerging cancer immunotherapy modality, has attracted much attention in recent years due to its power to selectively infect and eradicate tumor cells while simultaneously activating host anticancer immune responses.
Yining Wang
core +1 more source
NUT carcinoma (NC) is a rare, yet aggressive disease (median survival of 6.5 months) of the young defined by a translocation of the nuclear protein in testis gene 1 (NUTM1).
Rieka C. Buchenau +13 more
doaj +1 more source
Antitumor efficacy of systemically administered oncolytic adenoviruses (OAdv) is limited due to diverse factors such as liver sequestration, neutralizing interactions in blood, elimination by the immune system, and physical barriers in tumors.
R. Moreno +6 more
doaj +1 more source
Release the hounds: virotherapy with immunotherapy [PDF]
In this issue of Blood, Shen et al demonstrate that the vesicular stomatitis virus (VSV)-murine interferon β (IFNβ)-sodium iodide symporter (NIS) (VSV-mIFNβ-NIS) oncolytic virus has significant antileukemia activity, which is enhanced when combined with an anti-programmed death-ligand 1 (PD-L1) antibody.
openaire +2 more sources
Supplementary Figure 4 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid ...
Yasuo Urata (157765) +9 more
core +1 more source
Supplementary Figure 3 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid ...
Yasuo Urata (157765) +9 more
core +1 more source

